Gottlieb Adds A No. 2: Sherman Is US FDA Principal Deputy Commissioner
Rachel Sherman takes over a position that has not been filled permanently since Josh Sharfstein left in 2011.
You may also be interested in...
US FDA Taps Abernethy As Principal Deputy Commissioner; Health IT Exec Brings “Real-World” Expertise
Abernethy comes to FDA from Flatiron Health, which develops oncology-specific electronic health record software and real-world evidence for cancer research. She succeeds FDA veteran Rachel Sherman, who will retire from the agency in January.
Orphan, Combo, Pediatric Products Would See More Influence In Proposed US FDA Reorg
Reorganization also may force change to commissioner succession plan.